Posted by Two Blokes
Nike (NYSE:NKE) shares dropped more than 6% in pre-market today, as a disappointing revenue forecast for the f
Source: Two Blokes Trading
Posted by Two Blokes
Barclays analysts reaffirmed a $325 price target and Equalweight rating on Tesla (NASDAQ:TSLA), cautioning tha
Source: Two Blokes Trading
Posted by Two Blokes
Reddit (NYSE:RDDT) received a reaffirmed Buy rating and $220 price target from Needham analysts, even as the s
Source: Two Blokes Trading
Posted by Two Blokes
At NVIDIA’s GTC 2025 conference, CEO Jensen Huang dramatically shifted the narrative on quantum computin
Source: Two Blokes Trading
Posted by Two Blokes
Wall Street strategists have made modest adjustments to their year-end S&P 500 targets in response to soft
Source: Two Blokes Trading
Posted by Two Blokes
Tesla’s (NASDAQ: TSLA) stock, down 42% year-to-date and having given back the “Trump bump,”
Source: Two Blokes Trading
Posted by Two Blokes
Morgan Stanley maintains an Equal-Weight rating on NASDAQ:FIVE, with the stock priced at $79.93. Five Below r
Source: Two Blokes Trading
Posted by Two Blokes
Earnings Per Share (EPS) of $1.96 exceeded the Zacks Consensus Estimate, showcasing the company's ability to
Source: Two Blokes Trading
Posted by Two Blokes
Plus Therapeutics, Inc. (NASDAQ:PSTV) saw a 177.57% increase in stock price, likely due to FDA's conditi
Source: Two Blokes Trading
Posted by Two Blokes
NVIDIA Blackwell Ultra AI factory platform is set to revolutionize AI applications, potentially increasing NV
Source: Two Blokes Trading
Posted by Two Blokes
Alarum Technologies Ltd (NASDAQ:ALAR) reported earnings per share (EPS) of $0.01, missing the estimated $0.02
Source: Two Blokes Trading
Posted by Two Blokes
AbbVie offers an annual dividend of $6.56 per share, requiring an investment of approximately $32,224 to earn
Source: Two Blokes Trading